OptiMARK

· Guerbet

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for OptiMARK, covering 2017-08-01 to 2017-12-11. Get the full timeline:

Most recent: EMA Withdrawn: Optimark (gadoversetamide) — Mallinckrodt Deutschland GmbH